ArticleDigestive diseases and sciences2016
Gastric Electric Stimulation for Refractory Gastroparesis: A Prospective Analysis of 151 Patients at a Single Center.
Article in Digestive diseases and sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.
- The role of diet in diabetes gastroparesis treatment: a systematic review and meta-analysis.Frontiers in endocrinology · 2024Pooled it
- Pooled it
- Thrombosed external hemorrhoids during pregnancy: surgery versus conservative treatment.Updates in surgery · 2024Trial
- Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis.Neurogastroenterology and motility · 2020Trial
- Review
- Update on the Treatment of Autonomic Disorders.Current treatment options in neurology · 2025Article
- Difference in Cyclic Versus Non-cyclic Symptom Patterns in Patients with the Symptoms of Gastroparesis Undergoing Bioelectric Therapy.Digestive diseases and sciences · 2024Article
- Gastric peroral endoscopic pyloromyotomy (G-POEM) in patients with refractory gastroparesis: a review.Therapeutic advances in gastroenterology · 2023Review
- POEM, GPOEM, and ZPOEM.Digestive diseases and sciences · 2022Review
- Gastric Electrical Stimulation: Role and Clinical Impact on Chronic Nausea and Vomiting.Frontiers in neuroscience · 2022Review
- Both gastric electrical stimulation and pyloric surgery offer long-term symptom improvement in patients with gastroparesis.Surgical endoscopy · 2021Article
- EndoFLIP and Pyloric Dilation for Gastroparesis Symptoms Refractory to Pyloromyotomy/Pyloroplasty.Digestive diseases and sciences · 2021Article
- Noninvasive vagal nerve stimulation for gastroenterology pain disorders.Pain management · 2021Review
- Safety and Effectiveness of Tailored Hemorrhoidectomy in Outpatients Setting.Frontiers in surgery · 2021Article
- Endoscopic and Surgical Treatments for Gastroparesis: What to Do and Whom to Treat?Gastroenterology clinics of North America · 2020Review
- Therapies for diabetic gastroparesis: A protocol for a systematic review and network meta-analysis.Medicine · 2020Article
- Gastroparesis: New insights into an old disease.World journal of gastroenterology · 2020Review
- Functional outcome and quality of life evaluation of graciloplasty for the treatment of complex recto-vaginal and recto-urethral fistulas.Updates in surgery · 2020Article
- Letter to the Editor: Initial Experience with Endoscopic Pyloromyotomy, with Description and Video of Technique.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2019Article
- Natural orifice specimen extraction (NOSE) surgery with rectal eversion and total extra-abdominal resection.Techniques in coloproctology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric electric stimulation (GES) is used to treat patients with refractory gastroparesis symptoms. However, the effectiveness of GES in clinical practice and the effect of GES on specific symptoms of gastroparesis are not well delineated.
aimsTo determine the effectiveness of GES for treatment for refractory symptoms of gastroparesis, the improvement in specific symptoms of gastroparesis, and clinical factors impacting on outcome.
methodsEnterra GES was used to treat refractory gastroparesis symptoms. Patients filled out a symptom severity questionnaire (PAGI-SYM) prior to insertion. At each follow-up visit, the patient filled out PAGI-SYM and assessed their therapeutic response using the Clinical Patient Grading Assessment Scale (CPGAS).
resultsOne hundred and fifty-one patients (120 females) with refractory gastroparesis (72 diabetic, 73 idiopathic, 6 other) underwent GES. Of the 138 with follow-up (1.4 ± 1.0 years), the average CPGAS was 2.4 ± 0.3 (SEM): 104 patients (75 %) improved (CPGAS > 0) and 34 (25 %) did not (CPGAS ≤ 0). Sixty patients (43 %) were at least moderately improved (CPGAS score ≥4). Clinical improvement was seen in both diabetic and idiopathic patients with the CPGAS in diabetic patients (3.5 ± 0.3) higher in idiopathic patients (1.5 ± 0.5; p < 0.05). Symptoms significantly improving the most included nausea, loss of appetite, and early satiety. Vomiting improved in both diabetic and idiopathic patients although the diabetic subgroup experienced a significantly greater reduction in vomiting than the idiopathic subgroup.
conclusionsIn this cohort of patients with refractory gastroparesis, GES improved symptoms in 75 % of patients with 43 % being at least moderately improved. Response in diabetics was better than in nondiabetic patients. Nausea, loss of appetite, and early satiety responded the best.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.